GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Procter & Gamble Health PGHL.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

5,699.50

+2.58%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Procter & Gamble Health

Its shares trade on NSE under the ticker PGHL.NS. It has been listed since 21 November 1993. In the fiscal year to 31 December 2025, it reported revenue of ₹14.08bn and net income of ₹3.27bn. At that date it held total assets of ₹8.41bn and shareholders' equity of ₹5.25bn.

Procter & Gamble Health Ltd. engages in the manufacture and marketing of pharmaceuticals products. The company is headquartered in Mumbai, Maharashtra. The firm provides healthcare products. The company is involved in manufacturing and marketing over-the-counter vitamins, minerals, and supplements products for a healthy lifestyle. The firm offers brands, including Cosome, Neurobion, Livogen, SevenSeas, Evion, Polybion and Nasivion. The Company’s geographical segments include India and outside India. The company has its manufacturing facility situated at Usgaon, Goa. The firm has a sterile facility with a capacity of approximately 260 Mio ampoules per annum and a soft gel manufacturing site with a capacity of over 744 Mio capsules per annum. Its manufacturing site also exports to approximately 13 countries within P&G Personal Healthcare International.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
21 Nov 1993
Employees
1,368

Leadership

Pay as last reported

  • Mr. Suresh TalwarNon-Executive Independent Chairman of the Board, since 1984₹23,250
  • Mr. Lokesh ChandakChief Financial Officer, Executive Director, since 2023₹249,350
  • Ms. Zeal RupaniCompliance Officer, Company Secretary₹1.3m
  • Mr. Milind ThatteManaging Director, Executive Director, since 2018₹322,340
  • Mr. Aalok AgrawalNon-Executive Director
  • Ms. Seema SambasivanNon-Executive Director
  • Mrs. Rani JadhavNon-Executive Independent Director₹21,750
  • Mr. Subramanian MadhavanNon-Executive Independent Director₹22,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
71
Environment
68
Social
99
Governance
45
Direct emissions (scope 1)
263 t
Energy emissions (scope 2)
4,708 t
Women in the workforce
26%
Carbon reduction policy
No
Human rights policy
Yes

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Procter & Gamble Health Ltd benefits from several key strengths:

Weaknesses

  • Despite its strengths, Procter & Gamble Health Ltd also faces certain weaknesses:

Opportunities

  • Procter & Gamble Health Ltd can capitalize on the following opportunities:

Threats

  • Procter & Gamble Health Ltd should be wary of the following threats:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.